InvestorsHub Logo

H2R

Followers 41
Posts 2211
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Thursday, 10/19/2017 9:37:01 AM

Thursday, October 19, 2017 9:37:01 AM

Post# of 12138
SA: KITE Yescarta's OK bodes well for CryoPort


FDA OK for Kite's Yescarta bodes well for CryoPort

Oct. 19, 2017 7:52 AM ET|By: Douglas W. House, SA News Editor
The FDA's approval of Gilead Sciences' Kite Pharma's Yescarta (axicabtagene ciloleucel) should be bullish for CryoPort (NASDAQ:CYRX), who inked a deal with Kite last month to supply its cryogenic logistics solutions to support the product's commercial launch.

Freeze media supplier BioLife Solutions (NASDAQ:BLFS) is up 9% premarket on the basis of its contract with Kite.

Previously: CryoPort up 3% on deal with Kite Pharma for cryogenic support of axi-cel (Sept. 5)



https://seekingalpha.com/news/3302144-fda-ok-kites-yescarta-bodes-well-cryoport
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News